Systems, devices, and methods for administering cannabinoid mixtures
US-2024131279-A1 · Apr 25, 2024 · US
Nasal devices
US2017151397A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017151397-A1 |
| Application number | US-201615349533-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 11, 2016 |
| Priority date | Jul 2, 2002 |
| Publication date | Jun 1, 2017 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A nasal delivery device and a method of delivering substance to a nasal airway of a subject can be used for mass treatment, especially mass vaccination. The delivery device can include an interface unit, as a replaceable unit, having at least one nosepiece unit for fitting to a respective nostril of a subject, a nozzle from which substance is in use delivered, and at least one delivery unit having a substance supply unit for delivering substance to the nozzle of the at least one nosepiece unit. The delivery device can also include an actuation unit for actuating the at least one delivery unit of the interface unit.
First claim
Opening claim text (preview).
1 . (canceled) 2 . An interface unit comprising: a nosepiece for fitting to a first nostril of a subject, the nosepiece comprising a nozzle for delivery of a substance to the subject; and a substance supply unit from which the substance is delivered to the nozzle; wherein the interface unit is configured to be clipped to an actuation unit. 3 . The interface unit of claim 2 , wherein the interface unit is replaceable. 4 . The interface unit of claim 2 , wherein the substance is a powder. 5 . The interface unit of claim 2 , wherein the substance is a liquid. 6 . The interface unit of claim 2 , wherein the nosepiece comprises a cuff member for positioning the nosepiece within the first nostril of the subject. 7 . The interface unit of claim 2 , wherein the nozzle is configured to generate an aerosol spray. 8 . An interface unit comprising: a nosepiece for fitting to a first nostril of a subject, the nosepiece comprising a nozzle for delivery of a substance to the subject; and a substance supply unit from which the substance is delivered to the nozzle; wherein the interface unit is configured to be slidingly attached to an actuation unit. 9 . The interface unit of claim 8 , wherein the interface unit is replaceable. 10 . The interface unit of claim 8 , wherein the substance is a powder. 11 . The interface unit of claim 8 , wherein the substance is a liquid. 12 . The interface unit of claim 8 , wherein the nosepiece comprises a cuff member for positioning the nosepiece within the first nostril of the subject. 13 . The interface unit of claim 8 , wherein the nozzle is configured to generate an aerosol spray. 14 . An interface unit comprising: a nosepiece for fitting to a first nostril of a subject, the nosepiece comprising a nozzle for delivery of a substance to the subject; and a substance supply unit from which the substance is delivered to the nozzle, the substance supply unit containing a metered dose of the substance. 15 . The interface unit of claim 14 , wherein the interface unit is replaceable. 16 . The interface unit of claim 14 , wherein the interface unit is configured to be slidingly attached to an actuation unit. 17 . The interface unit of claim 14 , wherein the interface unit is configured to be clipped to an actuation unit. 18 . The interface unit of claim 14 , wherein the substance is a powder. 19 . The interface unit of claim 14 , wherein the substance is a liquid. 20 . The interface unit of claim 14 , wherein the nosepiece comprises a cuff member for positioning the nosepiece within the first nostril of the subject. 21 . The interface unit of claim 14 , wherein the nozzle is configured to generate an aerosol spray.
Assignees
Inventors
Classifications
Vaccines · CPC title
the dosages being arranged on a tape, e.g. strips · CPC title
on the body · CPC title
- A61M15/08Primary
Inhaling devices inserted into the nose · CPC title
Activated by exhalation · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2017151397A1 cover?
- A nasal delivery device and a method of delivering substance to a nasal airway of a subject can be used for mass treatment, especially mass vaccination. The delivery device can include an interface unit, as a replaceable unit, having at least one nosepiece unit for fitting to a respective nostril of a subject, a nozzle from which substance is in use delivered, and at least one delivery unit hav…
- Who is the assignee on this patent?
- Optinose As
- What technology area does this patent fall under?
- Primary CPC classification A61M15/08. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Jun 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).